6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 13, 2024 08:31 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 27, 2024 08:33 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Genetel Bioventures Limited(5.8%),Michael Yang Mengsu(5.8%)

Nov 14, 2024 12:34 ET

SCHEDULE 13G/A: Others

Nov 7, 2024 20:48 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 15, 2024 08:34 ET

6-K: Report of foreign private issuer (related to financial reporting)

Oct 7, 2024 08:43 ET

6-K: Report of foreign private issuer (related to financial reporting)

Sep 27, 2024 06:59 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 16, 2024 08:26 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 19, 2024 08:42 ET

6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Jul 11, 2024 09:48 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 11, 2024 08:08 ET

6-K: Report of foreign private issuer (related to financial reporting)

Jun 18, 2024 08:38 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 21, 2024 13:40 ET

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 1, 2024 13:20 ET

20-F: FY2023 Annual Report

May 1, 2024 13:20 ET

Prenetics Global | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 1, 2024 07:40 ET

Prenetics Global | EFFECT: Others

Feb 20, 2024 06:03 ET

Prenetics Global | 424B3: Prospectus

Feb 16, 2024 06:16 ET

Prenetics Global | CORRESP: CORRESP

Feb 14, 2024 22:18 ET

Prenetics Global | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)

Feb 5, 2024 07:42 ET